The aim of the Gulf Journal of Oncology is to provide a forum for the exchange of clinical and scientific information for Oncology community of the Gulf Cooperation Council (GCC) and the Arab world.

Manuscripts should be sent to :
The Gulf Federation for Cancer Control
General Secretary, State of Kuwait
Dr. K. Al-Saleh
Editor-in-Chief,
P.O. box 26733, Safat 13128
Tel. : 00965-2530186 /2530184
Fax : 00965-2510137
Email : gffccku@yahoo.com
Website : www.gffcc.org/journal

Instructions for Authors

General

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee, and therefore, have been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.

It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. No details that might disclose the identify of the subject’s under study should be mentioned. A patient must not be recognizable in photographs unless a written consent of the subject has been obtained.

A table or illustration that is published elsewhere should be accompanied by a reproducibility statement from the authors and publishers. Reports on animal experiments must state that the “Principle of laboratory animal care” were followed.

The editors reserve the right to reject manuscripts that do not comply with the above requirements. The author will be held responsible for false statements .

Text should be submitted on CD or by E-mail. The preferred word processing package is (MS-Word).

Do not use indentations. Enter your text continuously flush left. Arrange headings flush left. Insert only one space after punctuation marks. Store illustrations as separate files and do not integrate them in your text.

The text should be double spaced, with wide margins on one side of the paper only, and should be carefully prepared in the style of this Journal and reviewed before submission.

Typing errors should be corrected legibly.

Pages should be consecutively numbered, starting with the title page.

The desired position of figures and tables should be marked in the margin. Three copies should be submitted with each CD. In order to reduce mailing costs, manuscript will not be normally returned. Changes in the proofs should be kept to a minimum.

Short-Communications

Short communications represent a vehicle for rapidly disseminated novel ideas of great interest to the Oncology community, ideas which have not yet been extensively explored in a large clinical trial. Innovative work on machines, instruments, applicators, etc is most welcome.

Short communications should contain a maximum of 1200 – 1500 words and no more than 6 tables and/or figures, in whatever combination.

Tables and/or figures, should be prepared with appropriate, clear labels in a format of 8.6 x 8cm. References should be confined to 20.

Short communications should clearly state the aim of the study, materials, methods and patients, results, a brief discussion and a conclusion. Titles should be to the points and concise.

Preparation of Manuscript

Manuscript should be accompanied by a formal letter of request for publication which should be signed by the authors.

The speed of publication depends greatly upon following these guidelines precisely.

1. The manuscript should be divided clearly into an Introduction, Materials & Methods, Results, Discussion and References.

The Text should be concise and consistent as to spelling, abbreviation etc. They are most often subdivided into :

• Title Page

• Abstract

• Introduction (Not Headed)

• Methods

• Results

• Discussion

• List of References

• Acknowledgements

• Tables

• Illustrations

2. Title Page Should be a separate title page, including the name (s) degree and address ( es ) of author (s), It should be made clear which address relates to which authors.

A short running title containing not more then 50 characters and spacing should be included. The title page should be paginated as page 1 of the paper.

To facilitate communication between the Authors, Editors and Publisher, the author should furnish a fax number and or/an e-mail address on the title page of the manuscript.

Abstract

Should be a summary of the Hypothesis or Aims of the work, the basic material and method and the conclusion of the study.

The abstract should be normally of 150 – 250 words. Immediately following the abstract, up to five relevant Key Words should be supplied for subject indexing.

Introduction

The introduction should give a concise account of the background of problem and the objective of the investigation. Previous work should be quoted only if it has a bearing on the present problem.

Methods

Methods must be described in sufficient detail to allow the investigation to be interpreted and repeated by the readers. If the methods are commonly used, only a reference to the original source is required. Any modification of previously published methods should be described and reference given.

When a drug is first mentioned it should be given the generic or official name, followed in parentheses by chemical formula only if the structure is not well known.

Results

Description of results, should be concise and permit repetition of the investigation by others, data should not be repeated unnecessarily in text, table and figures. Significance should be given as values of probability.

The desired positions of tables and figures may be indicated by written instructions enclosed within lines and brackets, for example : [TABLE 2] near the paragraph

Discussion

The discussion should not merely repeat or recapitulate the results, but it should present their interpretation against the background of existing knowledge. It should include a statement of any assumptions on which conclusions are based.

Disclosure of any financial support should be clearly mentioned in the text with their source.

Acknowledgements

Acknowledgement will be printed in small type. They should be brief and should include reference to sources of support and sources of drugs not freely available commercially. Individuals named must be given the opportunity to read the paper an approve their inclusion in the acknowledgements.

1. References  

   • References should commence on a new page.

   • References must be numbered consecutively in the text by the order in which they are first mentioned in the text.

   • References in text, tables and legends should be identified by Arabic numbers appearing in the text in brackets and subscripted. eg. list ⁽³⁾.  

   • The names and initials of all authors should be listed.

   • Journals listed should be abbreviated according to the indêx Medicus format.

   • The number of references should preferably not exceed

   • 30-40 for review papers, 20-30 for original articles and 10-15 references for case reports.

   Examples of correct forms of references :
   Journal (Three Authors should be listed before using et al)

   1. Merrick GS, Buter WM, Dorsey AT, el al. Seed visibility in the prostatic and periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 2000;46:215-220.

   Chapter in a book

   2. Holl DF. Morphine in malignant pain. In: Smith F, Covino DM, eds, Acute pain. London: Butterworth’s, 1990; 200 – 210.

   Monographs

   3. Tito BD, Regional block, 5th Edn. Springfield, Madison Charles D. Thomas, 1989.

Tables

Tables must supplement, not duplicate, information in the text itself and be explanatory. Each table should have a title ( max. 5 words ) and to be submitted on a separate sheet or file .

Whenever there is referral to a table or a figure at the end of a sentence, the table should be between square bracket. e.g. [Table 2] and the figure between bracket e.g. (Fig. 4). No brackets or square to be used when referral is within the sentence.

Illustrations

Line drawings , graphs and charts should be submitted on word / power point or other IBM convertable format.